Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5673 - 5680 of 12008 results
Final Opioid Package: A Comparison of the House Package, Senate Package, and the Final Version
October 2, 2018| Blog| Viewpoint
Head of the Antitrust Division of the Department of Justice Announces Plan to Expedite the Merger Review Process and Put DOJ on a 6 Month Shot Clock
October 2, 2018| Advisory| Viewpoint
Association Health Plan Perspectives (Part 2): The Look-Through Rule and the Limits of State Regulatory Power
October 2, 2018| Blog| Viewpoint
New York State Department of Labor Releases Final Guidance Just Ahead of October 9, 2018 Compliance Deadline
October 2, 2018| Blog| Viewpoint
DV-2020 Diversity Visa Registration to Open
October 2, 2018| Advisory| Viewpoint
Medical Devices and the Intersection between FDA and Patent Law
October 2, 2018| Blog| Viewpoint
ML Strategies Weekly Health Care Preview - Week of October 1, 2018
October 1, 2018| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|